bf/NASDAQ:BMRN_icon.png

COM:BIOMARIN

BioMarin

  • Stock

Last Close

62.56

21/11 20:29

Market Cap

15.63B

Beta: -

Volume Today

857.75K

Avg: -

  • locale

    usUnited States
  • market

    STOCKS
  • industry

    Biotechnology
  • website

    www.biomarin.com
  • linkedin

    biomarin
  • founding date

    Mar 01, 1997
  • ipo date

    Jul 26, 1999

BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase fo...Show More

peer of

competitor of